Workday, Inc. (WDAY)


NYSE - NYSE Real Time Price. Currency in USD
84.91+5.26 (+6.60%)
As of 12:49 PM EDT. Market open.
People also watch:
NOWSPLKDATACRMPANW
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open85.36
Prev Close79.65
Bid84.82 x 200
Ask84.85 x 400
Day's Range82.49 - 85.96
52wk Range47.32 - 85.96
1y Target EstN/A
Market Cap16.73B
P/E Ratio (ttm)-52.71
Beta2.20
Volume6,743,611
Avg Vol (3m)1,615,282
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Mylan halts losing streak after EpiPen price cut, Tiffany shines, Dollar Tree declines
    Editor's Pick
    Yahoo Finance3 hours ago

    Mylan halts losing streak after EpiPen price cut, Tiffany shines, Dollar Tree declines

    Mylan (MYL) shares got a nice shot in the arm in early trading, halting its recent losing streak. The biotech firm said it will cut the cost of its EpiPen by half, through a savings card which will cover up to $300 of the EpiPen 2-pak. The move comes after increased pressure from Congress and Hillary Clinton over the skyrocketing cost of the allergy treatment.

  • A major price change for Mylan’s EpiPen 2-Pak
    Editor's Pick
    Yahoo Finance5 hours ago

    A major price change for Mylan’s EpiPen 2-Pak

    All three major averages (^DJI, ^GSPC, ^IXIC) were lower in early trading, as investors remained cautious ahead of a key speech by Fed Chair Janet Yellen Friday and despite some strong economic data. Separately, the Commerce Department reported that orders for durable goods increased by 4.4% last month. The biotech firm said it will cut the cost of its EpiPen by half, through a savings card which will cover up to $300 of the EpiPen 2-pak.

  • Barrons.com1 hour ago

    Workday Jumps 5%: Bulls Like the 'Positive Vibe'; Bears See A Short Squeeze

    Shares of cloud computing operation Workday (WDAY) are up $3.71, or almost 5%, at $83.36, retaining some of last night’s big jump, after the company yesterday afternoon reported fiscal Q2 revenue that slightly exceeded analysts’ expectations, but missed on the bottom line, and forecast this quarter’s revenue slightly below consensus. The stock has gotten price target increases at several shops, while revenue estimates are going slightly higher for this year, but most are now removing their expectation for profit this year, expecting a per-share loss instead. Berg today is sticking with that rating, while calling out some positives: The company reported what we believe is its largest HCM deal in several quarters and Financials deal flow that is much improved Y/Y. However, we believe the Financials deal flow likely support our recent checks that YTD Financials deal growth lags pipeline growth.